Mustafić Hazrije, Karimzadeh Soran, Park Chan-Il
Service cardiovasculaire, Hôpital de La Tour, 1217 Meyrin.
Rev Med Suisse. 2017 Mar 1;13(552):500-504.
Implantable cardioverter defibrillation has taken a predominant place in secondary and primary preventions of sudden rhythmic cardiac death in high-risk patients. However, in certain clinical situations, the implantation of definitive system should be postponed. The LifeVest, a portable external cardiac defibrillator system, has emerged as a novel therapeutic option before a final decision.
植入式心脏复律除颤器在高危患者心脏性猝死的二级和一级预防中占据了主导地位。然而，在某些临床情况下，确定性系统的植入应推迟。LifeVest，一种便携式体外心脏除颤器系统，已成为最终决策前的一种新型治疗选择。
